Investor FAQ

Where is Generate:Biomedicines headquartered?

101 South Street, Suite 900, Somerville, MA, 02143

When and where was Generate:Biomedicines incorporated?

August 2018 in Delaware

When did Generate:Biomedicines go public?

Generate:Biomedicines began trading on The Nasdaq Stock Market on February 27, 2026

What is Generate:Biomedicines’ fiscal year-end?

December 31

How is Generate:Biomedicines’ stock traded and what is its CUSIP number?

Generate:Biomedicines is traded on The Nasdaq Stock Market under the ticker symbol GENB and its CUSIP number is 370920100

Does Generate:Biomedicines pay dividends on its common stock?

No, the company does not currently anticipate declaring or paying, for the foreseeable future, any distributions on our capital stock

Who is Generate:Biomedicines’ transfer agent?

Computershare is our transfer agent and registrar. You can contact them with any questions about your share ownership through any of the methods below:

Email: web.queries@computershare.com
Website: www.computershare.com/us
Phone: + 1 (800) 736-3001 (U.S.) and +1 (781) 575-3100 (non U.S.)
By Mail: Computershare P.O. Box 43006 Providence RI 02940-3006
By Overnight Delivery: Computershare 150 Royall St., Suite 101 Canton MA 02021

How can I reach the investor relations team?

Inquiries can be submitted to investors@generatebiomedicines.com

How do I access Generate:Biomedicines’ compliance hotline?

That number is +1 (888)-547-1235